West Nile Virus and Plasma-Derived Products FDA Blood Product Advisory Committee Meeting 18 September 2003. Mahmood Farshid, Ph.D. Division of Hematology OBRR, CBER. Current Review Approach for Viral Clearance Studies in Human Blood Derived Products.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Mahmood Farshid, Ph.D.
Division of Hematology
2. Whether the clearance steps in the manufacture of plasma derivatives obviate the need to screen donations of source plasma ( this issue will not be addressed further, pending FDA review of additional data requested of the plasma industry)
Source: Data Submitted to CBER by 3 Manufacturers of Plasma derived products
* Pasteurization or vapor heat